SHARING IDEAS THAT DO GOOD

New drug for treating melanoma and other cancers

post-image
Researchers at the University of Colorado Cancer Centre have published their work on NLRP3 - an intracellular complex found to participate in melanoma-mediated inflammation leading to tumour growth and progression. The researchers found that by inhibiting this complex, they can reduce inflammation and tumour growth. The studies have so far used an oral NLRP3 inhibitor (Dapansutrile) which has shown to be effective in treating gout and heart disease. It is currently being tested in COVID-19.  | https://medicalxpress.com/news/2021-04-drug-tumors.html?utm_source=nwletter&utm_medium=email&utm_campaign=daily-nwletter
What do you think?

You must be logged in to post a comment.
Comments
Generic placeholder image

By Mel Raassina

9 April 2021



Related Posts

Healthcare

post-image

Being Covid-Safe Now Means Wearing N95 Masks
18 January 2022 by Maria MacNama... 1 Comments
 

Healthcare

post-image

An exoskeleton that neutralises spasms
4 January 2022 by Lynn Wood 0 Comments

Healthcare

post-image

An eye-drop that improves close range vision
3 January 2022 by Lynn Wood 0 Comments